Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy
Recruiting · Phase 1, Phase 2 · NCT04113382
Conditions: Bowel Preparation
At a glance
- Research payments reported, 2025
- $126,834
- U.S. investigators named
- 5
- Sites paid
- 5
- Planned or actual enrollment
- 39
About the trial
- Sponsor
- Ferring Pharmaceuticals
- Tested
- CLENPIQ (drug), MIRALAX (drug), SENNA (drug)
- Dates
- Started 2022-06-23; completion 2027-12
- Results posted
- Not yet
Bowel preparation for pediatric colonoscopy.
From ClinicalTrials.gov, last updated 2026-09-04. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Ferring International Pharmascience Center US reported $126,834 in research payments for this study in 2025 (17 payments).
Products named: Clenpiq
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- David A. Gremse, M.D. Pediatric Gastroenterology · Mobile, AL
- Jeannie S. Huang, M.D. Pediatric Gastroenterology · San Diego, CA
- Kenneth Ng, D.O. Pediatric Gastroenterology · Baltimore, MD
- Runa D. Watkins, M.D. Pediatrics · Baltimore, MD
- Lidija Palezac Pediatric Gastroenterology · Bronx, NY
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- South Alabama Medical Science Foundation $82,007
- University of Maryland Baltimore $24,500
- Biomedical Research Alliance of New York LLC $10,465
- The Regents of the University of California San Diego $9,600
- Johns Hopkins University $262
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.